Tetraspanins in Digestive‑system Cancers: Expression, Function and Therapeutic Potential (Review)

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2024 Sep 6

PMID 39239742

Authors

Kexin Chen

Qiuhong Li

Yangyi Li

Donghui Jiang

Ligang Chen

Jun Jiang

Shengbiao Li

Chunxiang Zhang

Affiliations

Soon will be listed here.

Abstract

The tetraspanin family of membrane proteins is essential for controlling different biological processes such as cell migration, penetration, adhesion, growth, apoptosis, angiogenesis and metastasis. The present review summarized the current knowledge regarding the expression and roles of tetraspanins in different types of cancer of the digestive system, including gastric, liver, colorectal, pancreatic, esophageal and oral cancer. Depending on the type and context of cancer, tetraspanins can act as either tumor promoters or suppressors. In the present review, the importance of tetraspanins in serving as biomarkers and targets for different types of digestive system‑related cancer was emphasized. Additionally, the molecular mechanisms underlying the involvement of tetraspanins in cancer progression and metastasis were explored. Furthermore, the current challenges are addressed and future research directions for advancing investigations related to tetraspanins in the context of digestive system malignancies are proposed.

References

Wunder J, Eppert K, Burrow S, Gokgoz N, Bell R, Andrulis I . Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene. 1999; 18(3):783-8. DOI: 10.1038/sj.onc.1202346. View

Feng J, Huang C, Wren J, Wang D, Yan J, Zhang J . Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity. Cancer Metastasis Rev. 2015; 34(4):619-33. DOI: 10.1007/s10555-015-9585-x. View

Liu T, Zu C, Wang S, Song H, Wang Z, Xu X . PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells. Oncotarget. 2016; 7(28):43376-43389. PMC: 5190030. DOI: 10.18632/oncotarget.9716. View

Murray D, Horgan G, MacMathuna P, Doran P . NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. Br J Cancer. 2008; 99(8):1322-9. PMC: 2570507. DOI: 10.1038/sj.bjc.6604688. View

Qin Y, Yang J, Liang C, Liu J, Deng Z, Yan B . Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation. Front Immunol. 2022; 13:994828. PMC: 9669594. DOI: 10.3389/fimmu.2022.994828. View

Pan S, Wu Y, Cai S, Pan Y, Liu W, Bian L . Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression. Biochem Biophys Res Commun. 2015; 458(3):476-482. DOI: 10.1016/j.bbrc.2015.01.128. View

Wang J, Zhou Y, Li D, Sun X, Deng Y, Zhao Q . TSPAN31 is a critical regulator on transduction of survival and apoptotic signals in hepatocellular carcinoma cells. FEBS Lett. 2017; 591(18):2905-2918. DOI: 10.1002/1873-3468.12737. View

Wang H, Rana S, Giese N, Buchler M, Zoller M . Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells. Int J Cancer. 2013; 133(2):416-26. DOI: 10.1002/ijc.28044. View

Buim M, Lourenco S, Carvalho K, Cardim R, Pereira C, Carvalho A . Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma. Oral Oncol. 2010; 46(3):166-71. DOI: 10.1016/j.oraloncology.2009.11.009. View

10.

Otsubo C, Otomo R, Miyazaki M, Matsushima-Hibiya Y, Kohno T, Iwakawa R . TSPAN2 is involved in cell invasion and motility during lung cancer progression. Cell Rep. 2014; 7(2):527-538. DOI: 10.1016/j.celrep.2014.03.027. View

11.

Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B . Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene. 2001; 20(50):7437-46. DOI: 10.1038/sj.onc.1204935. View

12.

Liu X, Guo X, Li H, Chen J, Qi X . Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer. Mol Med Rep. 2016; 13(6):4774-8. DOI: 10.3892/mmr.2016.5093. View

13.

Devbhandari R, Shi G, Ke A, Wu F, Huang X, Wang X . Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma. PLoS One. 2011; 6(9):e24901. PMC: 3178554. DOI: 10.1371/journal.pone.0024901. View

14.

Berditchevski F, Gilbert E, Griffiths M, Fitter S, Ashman L, Jenner S . Analysis of the CD151-alpha3beta1 integrin and CD151-tetraspanin interactions by mutagenesis. J Biol Chem. 2001; 276(44):41165-74. DOI: 10.1074/jbc.M104041200. View

15.

Visvader J . Cells of origin in cancer. Nature. 2011; 469(7330):314-22. DOI: 10.1038/nature09781. View

16.

Zeng T, Zheng B, Zheng W, Chen C . CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1. Eur Rev Med Pharmacol Sci. 2018; 22(18):5928-5937. DOI: 10.26355/eurrev_201809_15922. View

17.

Suzuki M, Tachibana I, Takeda Y, He P, Minami S, Iwasaki T . Tetraspanin CD9 negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation. J Immunol. 2009; 182(10):6485-93. DOI: 10.4049/jimmunol.0802797. View

18.

Qi Y, Qi W, Liu S, Sun L, Ding A, Yu G . TSPAN9 suppresses the chemosensitivity of gastric cancer to 5-fluorouracil by promoting autophagy. Cancer Cell Int. 2020; 20:4. PMC: 6942356. DOI: 10.1186/s12935-019-1089-2. View

19.

Kim J, Badawi M, Park J, Jiang J, Mo X, Roberts L . Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151. Int J Oncol. 2016; 49(5):2037-2045. DOI: 10.3892/ijo.2016.3677. View

20.

Anami K, Oue N, Noguchi T, Sakamoto N, Sentani K, Hayashi T . TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer. Gastric Cancer. 2015; 19(2):370-380. DOI: 10.1007/s10120-015-0478-z. View